Drugs / Podophyllin
Trials 0
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT06809777 Comparator | Jun → Nov 2025 overdue | anogenital human papillomavirus infection | Sheikh Zayed Medical College | Not yet recruiting | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT03853785 Comparator | Feb 2020 → Feb 2021 | anogenital human papillomavirus infection | Assiut University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Podophyllin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03853785 ↗ |
| Route | Topical | “25% podophyllin resin will be applied topically once weekly for 4 weeks” NCT06809777 ↗ |